Risk of heavy and/or prolong vaginal bleeding Risk of hypersensitivity to DMPA or Implanon Time consuming for recording menstrual diary and follow up
Conditions
Interventions
1.Computerized Randomization : Block of 4 for selecting subjects to subdermal single rod implant (Implanon)or intramuscularly injectable contraceptive ( DMPA) group.
2.Recording dermographic data of e
we will record weight,
other side effects and satisfaction of subjects.,1.Computerized Randomization : Block of 4 for selecting subjects to subdermal single rod implant (Implanon)or intramuscularly injectable contraceptive
other side effects and satisfaction of subjects.
Experimental Drug,Experimental Drug
subdermal single rod implant (Implanon),intramuscularly injectable contraceptive ( DMPA)
Sponsors
Faculty of Siriraj hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1.Reproductive women age 18-45 years old want to use DMPA or Implanon 2.Normal healthy, Doesn't use and medications. 3.Normal menstrual cycle (last from 21-32 day with 2-6 days) at least 3 cycles 4.Women who have side effects from other method.
Exclusion criteria
Exclusion criteria: 1.Post partum women ( 6 weeks apart from delivery) 2.Breast feeding women 3.Women who have abnormal vaginal bleeding related disease such as PCOS, cervical cancer, subserous myoma, adenomyosis 4.Women who recieve hormaone 3 months befor enrollment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Unschedule vaginal bleeding 6 Months qui square test | — |
Secondary
| Measure | Time frame |
|---|---|
| Normal menstrual cycle 6 Months qui square test,Amenorrhea 6 Months qui square test,Weight gain 6 Months Average of weight gain,Efficacy 6 Months peal index,Other side effects 6 Months Percentage,Satisfaction 6 Months Average of number score | — |
Countries
Thailand
Contacts
Public ContactManopchai Thamkhantho
Siriraj hospital
Outcome results
None listed